We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pradaxa Maker Denied JMOL, New Trial In $1.7M Bleeding Injury Trial

Mealey's (May 20, 2019, 8:48 AM EDT) -- HUNTINGDON, W.Va. — A West Virginia federal judge on May 15 denied judgment as a matter of law (JMOL) or a new trial to drug maker Boehringer Ingelheim Pharmaceuticals Inc. in...
To view the full article, register now.